The oral side of Sjögren syndrome. Diagnosis and treatment. A review (Q34557192)

3 August 2017

1 reference

title

The oral side of Sjögren syndrome. Diagnosis and treatment. A review (English)

1 reference

3 August 2017

Armando Ernesto Soto-Rojas

series ordinal

1

1 reference

PubMed ID

11886706

3 August 2017

Arnoldo Kraus

series ordinal

2

1 reference

PubMed ID

11886706

3 August 2017

language of work or name

1 reference

1 March 2002

1 reference

Archives of Medical Research

3 August 2017

1 reference

3 August 2017

33

1 reference

3 August 2017

2

1 reference

3 August 2017

95-106

1 reference

Sjögren's syndrome. Proposed criteria for classification

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Follow up study of labial salivary gland lesions in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Focal lymphocytic infiltration in the human labial salivary glands: a postmortem study

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

The salivary gland component of Sjögren's syndrome: an evaluation of diagnostic methods

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Progression of sialadenitis in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Methods for collecting saliva

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

The role of salivary measurements in the diagnosis of salivary autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Whole saliva and the diagnosis of Sjögren's syndrome: an evaluation of patients who complain of dry mouth and dry eyes. Part 2: Immunologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

The diagnostic value of salivary gland scintigraphy in patients suspected of primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Scintigraphic features of chronic sialadenitis and Sjögren's syndrome: a comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

The diagnostic value of salivary fluid levels of beta 2-microglobulin, lysozyme and lactoferrin for primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Saliva: an additional diagnostic tool in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Diagnostic significance of salivary levels of beta 2-microglobulin in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Beta 2 microglobulin measurements in saliva of patients with primary Sjögren's syndrome: influence of flow

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Salivary electrophoresis in the diagnosis of Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Isotype distribution of anti-Ro/SS-A and anti-La/SS-B antibodies in plasma and saliva of patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

The place of magnetic resonance and ultrasonographic examinations of the parotid gland in the diagnosis and follow-up of primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Magnetic resonance imaging of the parotid glands and lip biopsy in the evaluation of xerostomia in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Does autonomic nervous impairment have a role in pathophysiology of Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Sjögren's syndrome-time for a new approach

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

An alternative perspective to the immune response in autoimmune exocrinopathy: induction of functional quiescence rather than destructive autoaggression

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Impaired microvascular response to cholinergic stimuli in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Early dental loss in Sjögren's syndrome. Histologic correlates. European Community Study Group on Diagnostic Criteria for Sjögren's Syndrome (EEC COMAC)

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Prevalence of periodontal disease in patients with Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

The periodontal status of patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Periodontal status and serum antibody responses to oral microorganisms in Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Respiratory function in systemic lupus erythematosus: relation with activity and severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Management for the highly caries-susceptible patient

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Caries prevention: current strategies, new directions

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Treatment regimens in preventive and restorative dentistry

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Whole saliva and the diagnosis of Sjögren's syndrome: an evaluation of patients who complain of dry mouth and dry eyes. Part 1: Screening tests

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

The level of cariogenic micro-organisms in patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Chlorhexidine rinse in prevention of dental caries in patients following radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Current treatment modalities of oral problems of patients with Sjögren's syndrome: caries prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

A preliminary assessment of intra-oral lubricating systems for dry mouth patients

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

The effect of increased mastication by daily gum-chewing on salivary gland output and dental plaque acidogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

Comparison of the effect of the linseed extract Salinum and a methyl cellulose preparation on the symptoms of dry mouth

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

The use of milk as a saliva substitute

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900371-X

7 January 2021

10.1016/S0188-4409(01)00371-X

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11886706